BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20497911)

  • 21. [Targeted therapy of sarcomas].
    Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
    Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Soft tissue sarcomas: clinical application of molecular biology].
    Chetaille B; Laibe S; Choukeir N; Bertucci F
    Rev Prat; 2013 Mar; 63(3):309-13. PubMed ID: 23687749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapy of soft tissue sarcomas.
    Wardelmann E; Chemnitz JM; Wendtner CM
    Onkologie; 2012; 35 Suppl 1():21-7. PubMed ID: 22286584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Targeted treatment of rare connective tissue tumors and sarcomas].
    Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
    Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular biology of sarcoma and therapeutic choices].
    Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
    Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular biology of soft-tissue sarcomas].
    Coindre JM
    Bull Cancer; 2010 Nov; 97(11):1337-45. PubMed ID: 21084242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
    Penel N; Lebellec L; Blay JY; Robin YM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102960. PubMed ID: 32320927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Soft tissue sarcomas: update on molecular data].
    Bui Nguyen Binh M; Collin F; Coindre JM
    Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of sarcoma development.
    Helman LJ; Meltzer P
    Nat Rev Cancer; 2003 Sep; 3(9):685-94. PubMed ID: 12951587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
    Riedel RF
    Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical treatment of soft tissue sarcomas based on the histological subtype].
    Pápai Z
    Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.
    Rutkowski P; Przybył J; Świtaj T
    Int J Biochem Cell Biol; 2014 Aug; 53():466-74. PubMed ID: 24704529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
    Riggi N; Cironi L; Suvà ML; Stamenkovic I
    J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of sarcomagenesis.
    Matushansky I; Maki RG
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):427-49, v. PubMed ID: 15939190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 1 clinical trials for sarcomas: the cutting edge.
    Subbiah V; Kurzrock R
    Curr Opin Oncol; 2011 Jul; 23(4):352-60. PubMed ID: 21519259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapies for sarcomas: new roles for the pathologist.
    Al-Zaid T; Somaiah N; Lazar AJ
    Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.